Cite
HARVARD Citation
Shinoda, K. et al. (2015). CD30 ligand is a new therapeutic target for central nervous system autoimmunity. Journal of autoimmunity. pp. 14-23. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shinoda, K. et al. (2015). CD30 ligand is a new therapeutic target for central nervous system autoimmunity. Journal of autoimmunity. pp. 14-23. [Online].